Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1

[21] Oike F(2008)Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation Clin Chim Acta 388 51-58

[22] Ogura Y(2005)Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11 Hepatology 41 916-924

[23] Sakamoto S(2010)Lysophosphatidic acid is a potential mediator of cholestatic pruritus Gastroenterology 139 1008-1018

[24] Kasahara M(2010)The 5-D itch scale: a new measure of pruritus Br J Dermatol 162 587-593

[25] Ogawa K(2010)Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate Hepatology 51 286-296

[26] Miyagawa-Hayashino A(2008)Two pathways for lysophosphatidic acid production Biochim Biophys Acta 1781 513-518

[27] Yonekawa Y(2013)The TGR5 receptor mediates bile acid-induced itch and analgesia J Clin Invest 123 1513-1530

[28] Yorifuji T(2013)Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET Nucl Med Biol 40 912-918

[29] Watanabe K(2001)FIC1 disease: a spectrum of intrahepatic cholestatic disorders Semin Liver Dis 21 535-544

[30] Doi H(undefined)undefined undefined undefined undefined-undefined

[21] Oike F(2008)Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation Clin Chim Acta 388 51-58

[22] Ogura Y(2005)Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11 Hepatology 41 916-924

[23] Sakamoto S(2010)Lysophosphatidic acid is a potential mediator of cholestatic pruritus Gastroenterology 139 1008-1018

[24] Kasahara M(2010)The 5-D itch scale: a new measure of pruritus Br J Dermatol 162 587-593

[25] Ogawa K(2010)Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate Hepatology 51 286-296

[26] Miyagawa-Hayashino A(2008)Two pathways for lysophosphatidic acid production Biochim Biophys Acta 1781 513-518

[27] Yonekawa Y(2013)The TGR5 receptor mediates bile acid-induced itch and analgesia J Clin Invest 123 1513-1530

[28] Yorifuji T(2013)Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET Nucl Med Biol 40 912-918

[29] Watanabe K(2001)FIC1 disease: a spectrum of intrahepatic cholestatic disorders Semin Liver Dis 21 535-544

[30] Doi H(undefined)undefined undefined undefined undefined-undefined